The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prognostic factors of response to adjuvant chemotherapy after curative resection for pancreatic ductal adenocarcinoma: Prognostic impact of CDA, predictive value of DPD for 5FU efficiency, and hENT1 for gemcitabine.
Xavier Edouard Truchet
No relevant relationships to disclose
Claire Mallaret
No relevant relationships to disclose
Véronique Secq
No relevant relationships to disclose
Julien Mancini
No relevant relationships to disclose
Yves patrice le Treut
No relevant relationships to disclose
Vincent Moutardier
No relevant relationships to disclose
Mehdi Ouaïssi
No relevant relationships to disclose
Marion Rubis
No relevant relationships to disclose
Emilie Nouguered
No relevant relationships to disclose
Jean Delgrande
No relevant relationships to disclose
marie-Noëlle Lavaut
No relevant relationships to disclose
Joseph Ciccolini
No relevant relationships to disclose
Mohamed Gasmi
No relevant relationships to disclose
Stéphane Garcia
No relevant relationships to disclose
Jean Francois Seitz
No relevant relationships to disclose
Laetitia Dahan
No relevant relationships to disclose